8-K current report · filed Oct 15, 2026

Olema Pharmaceuticals, Inc. (OLMA) 8-K Current Report: October 15, 2026

Item 5.02OLMA overview

Short answer

Olema Pharmaceuticals, Inc. (OLMA) filed an 8-K current report with the SEC on October 15, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Dr. Gorjan Hrustanovic resigned from the Board effective October 14, 2026.

Olema Pharmaceuticals, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Dr. Gorjan Hrustanovic resigned from the Board effective October 14, 2026
  • Committee departures included Compensation and Science and Technology committees
  • Resignation unrelated to disagreements over operations, policies or practices
  • Dr. Prakash Raman appointed to both committees effective October 15, 2026

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Olema Pharmaceuticals, Inc. 8-K filings

Get the next OLMA 8-K as it lands

Follow OLMA for push alerts, or ask the research agent what this filing means.